Condition
Bone Loss of Substance
Total Trials
1
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
1 treatments under study, led by Msv Treatment
Research Leaders
5 sponsors active, led by Red de Terapia Celular
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Phase 1/2 (1)
Trial Status
Completed1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Common Treatments
- Msv Treatment1
Active Sponsors
- Red de Terapia Celular1
- Sanidad de Castilla y León1
- University of Valladolid1
- Citospin1
- Centro en Red de Medicina Regenerativa de Castilla y Leon1
Top Investigators
University of Valladolid, Spain
Centro Andaluz de Nanomedicina y Biotecnología (BIONAND), Universidad de Málaga, Ciber-bbn. Málaga, Spain.
Instituto de Biología y Genética Molecular (IBGM), University of Valladolid, Spain
Oral and Maxillofacial Surgeon, Río Hortega University Hospital, SACYL, Valladolid, Spain
Related Conditions
- Maxillary Cyst1